These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 394320

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S, Nath V, Coyne DW.
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Prognostic significance of controlled and uncontrolled arterial hypertension in patients with terminal kidney failure on chronic hemodialysis].
    Milovanova LIu, Nikolaev AIu, Lifshits NL, Milovanov IuS.
    Ter Arkh; 2002; 74(6):45-9. PubMed ID: 12136483
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Causes of chronic renal failure and clinical status of patients during initiation of hemodialysis therapy in upper Silesian region].
    Zarzecki M, Chudek J, Kułach A, Hołowiecka A, Kania M, Kopeć P, Kukla M, Machała L, Pyda M, Rozmus W, Szpak S, Wiecek A.
    Wiad Lek; 2004; 57(3-4):145-50. PubMed ID: 15307522
    [Abstract] [Full Text] [Related]

  • 27. Captopril in hypertension after renal transplantation.
    Herlitz H, Ahlmén J, Aurell M, Blohmé I, Brynger H, Delin K, Larsson O.
    Scand J Urol Nephrol Suppl; 1984; 79():111-4. PubMed ID: 6382584
    [Abstract] [Full Text] [Related]

  • 28. [Importance of the sodium content of the dialytic fluid in periodic hemodialysis. Data on the behavior of arterial pressure, corporeal sodium pattern and the plasma renin activity in some hypertensive, chronic uremic patients treated with dialysis with a bath with varying sodium content].
    Romagnoli GF, Huber W, Di Landro D, Bertoli M, Antonello A, Cerutti M, Chini M.
    Minerva Nefrol; 1975; 22(4-5):205-11. PubMed ID: 1207978
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
    Wambach G, Godehardt E, Lang R, Haerlin R, Meurer KA.
    Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical and laboratorial characteristics associated with biopsy proved hypertensive nephroangiosclerosis].
    D'Oliveira CH, Martin LC, Viero RM, Cerolli CF, Moraes CE, Silva Vdos S, Habermann F, Franco RJ.
    J Bras Nefrol; 2011 Aug; 33(3):322-8. PubMed ID: 22042349
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Plasma renin activity and prognosis of chronic glomerulonephritis without hemodialysis treatment].
    Kaneko Y, Takeda T, Ishii M, Ikeda T, Yagi S.
    Nihon Rinsho; 1974 Oct; 32(10):3081-90. PubMed ID: 4475167
    [No Abstract] [Full Text] [Related]

  • 35. Symptomatic renal artery stenosis superimposed on chronic glomerulonephritis.
    Modai D, Cohen N, Weissgarten J, Segal B, Pik A.
    Isr J Med Sci; 1985 Apr; 21(4):366-9. PubMed ID: 3158624
    [Abstract] [Full Text] [Related]

  • 36. Propranolol in hypertensive dialysis patients: efficacy and compliance.
    Briggs WA, Lowenthal DT, Cirksena WJ, Price WE, Gibson TP, Flamenbaum W.
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):606-12. PubMed ID: 1183140
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The value of aggressive therapy in the hypertensive patient with azotemia.
    Mroczek WJ, Davidov M, Gavrilovich L, Finnerty FA.
    Circulation; 1969 Dec; 40(6):893-904. PubMed ID: 5387363
    [No Abstract] [Full Text] [Related]

  • 39. [Furosemide treatment of renal insufficiency complicated by hypertension].
    Iida N, Shirai D, Iwasaki E, Okada N, Uchisaka T.
    Nihon Jinzo Gakkai Shi; 1977 Aug; 19(8):641-50. PubMed ID: 926437
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of reversible, uremia-inducing factors in chronic interstitial nephritis].
    Sterzel RB.
    Dtsch Med Wochenschr; 1975 Feb 07; 100(6):252-4. PubMed ID: 1112247
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.